Sharecare (SHCR)
(Real Time Quote from BATS)
$1.37 USD
-0.01 (-0.73%)
Updated Aug 8, 2024 03:55 PM ET
After-Market: $1.37 0.00 (0.00%) 4:14 PM ET
3-Hold of 5 3
C Value C Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.37 USD
-0.01 (-0.73%)
Updated Aug 8, 2024 03:55 PM ET
After-Market: $1.37 0.00 (0.00%) 4:14 PM ET
3-Hold of 5 3
C Value C Growth D Momentum D VGM
Zacks News
Alignment Healthcare (ALHC) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Alignment Healthcare (ALHC) delivered earnings and revenue surprises of 7.14% and 7.66%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Sharecare, Inc. (SHCR) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Sharecare (SHCR) delivered earnings and revenue surprises of 0% and 12.47%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Sharecare, Inc. (SHCR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Sharecare (SHCR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sharecare, Inc. (SHCR) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
Sharecare (SHCR) delivered earnings and revenue surprises of -200% and 7.56%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
GoodRx Holdings, Inc. (GDRX) Matches Q4 Earnings Estimates
by Zacks Equity Research
GoodRx Holdings, Inc. (GDRX) delivered earnings and revenue surprises of 0% and 0.54%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Life Time Group Holdings, Inc. (LTH) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Life Time Group Holdings, Inc. (LTH) delivered earnings and revenue surprises of 111.11% and 0.27%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Astrana Health Inc. (ASTH) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Astrana Health Inc. (ASTH) delivered earnings and revenue surprises of 52.94% and 1.93%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Down -26.15% in 4 Weeks, Here's Why Sharecare, Inc. (SHCR) Looks Ripe for a Turnaround
by Zacks Equity Research
Sharecare, Inc. (SHCR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Sharecare, Inc. (SHCR) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Sharecare, Inc. (SHCR) delivered earnings and revenue surprises of 0% and 0.21%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Life Time Group Holdings, Inc. (LTH) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Life Time Group Holdings, Inc. (LTH) delivered earnings and revenue surprises of -20% and 0.90%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Sharecare, Inc. (SHCR) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Sharecare, Inc. (SHCR) delivered earnings and revenue surprises of 25% and 4.66%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
InnovAge Holding Corp. (INNV) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
InnovAge Holding Corp. (INNV) delivered earnings and revenue surprises of 0% and 1.14%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Viatris (VTRS) Tops Q1 Earnings Estimates
by Zacks Equity Research
Viatris (VTRS) delivered earnings and revenue surprises of 13.04% and 1.75%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
After Plunging -41.08% in 4 Weeks, Here's Why the Trend Might Reverse for Sharecare, Inc. (SHCR)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Sharecare, Inc. (SHCR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Ascend Wellness Holdings, Inc. (AAWH) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Ascend Wellness Holdings, Inc. (AAWH) delivered earnings and revenue surprises of -700% and 2.88%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Biodesix, Inc. (BDSX) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Biodesix, Inc. (BDSX) delivered earnings and revenue surprises of -7.69% and 10.23%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Alignment Healthcare (ALHC) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Alignment Healthcare (ALHC) delivered earnings and revenue surprises of -3.33% and 6.10%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Sharecare, Inc. (SHCR) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Sharecare, Inc. (SHCR) delivered earnings and revenue surprises of 80% and 2.49%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?